SANGUINE CORP
SB-2, EX-23, 2000-11-01
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: SANGUINE CORP, SB-2, EX-5, 2000-11-01
Next: SANGUINE CORP, SB-2, EX-27, 2000-11-01




                     [Letterhead of Branden T. Burningham]


October 31, 2000

Thomas C. Drees, Ph.D., MBA, President
Sanguine Corporation
110 East Green Street, #11
Pasadena, California 91105


Re:  Opinion letter, dated October 31, 2000, regarding shares of common stock
     of Sanguine Corporation, a Nevada corporation (the "Company")


Dear Dr.Drees:

     I hereby consent to being named in the Prospectus included in the
Company's Registration Statement on Form SB-2 as having rendered the above-
referenced opinion and as having represented the Company in connection with
such Registration Statement.

                                                  Sincerely yours,

                                                  /s/ Branden T. Burningham

                                                  Branden T. Burningham


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission